PHLPP1 has been described as a tumor suppressor in prostate cancer [88] and there are preliminary findings that aberrant expression of PHLPP1/2 may be associated with poor prognosis in several cancers [89,90,91]. Here, PHLPP1 is linked to prostate carcinoma.